skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,099  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
Material Type:
Article
Add to My Research

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience

Open heart, 2020-02, Vol.7 (1), p.e001144-e001144 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2019-001144 ;PMID: 32180986

Full text available

2
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
Material Type:
Article
Add to My Research

Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension

British journal of cancer, 2023-01, Vol.128 (2), p.354-362 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;The Author(s), under exclusive licence to Springer Nature Limited 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-022-02036-6 ;PMID: 36357702

Full text available

3
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension
Material Type:
Article
Add to My Research

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Open heart, 2024-05, Vol.11 (1), p.e002710 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002710 ;PMID: 38719497

Full text available

4
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
Material Type:
Article
Add to My Research

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

British journal of cancer, 2022-02, Vol.126 (2), p.265-274 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. corrected publication 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021, corrected publication 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01557-w ;PMID: 34616010

Full text available

5
Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study
Material Type:
Article
Add to My Research

Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study

British journal of cancer, 2022-11, Vol.127 (11), p.1974-1982 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;The Author(s), under exclusive licence to Springer Nature Limited 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-022-01975-4 ;PMID: 36138074

Full text available

6
Hypertension in malignancy-an underappreciated problem
Material Type:
Article
Add to My Research

Hypertension in malignancy-an underappreciated problem

Oncotarget, 2018-04, Vol.9 (29), p.20855-20871

Copyright: © 2018 Małyszko et al. 2018 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.25024 ;PMID: 29755695

Full text available

7
Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
Material Type:
Article
Add to My Research

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

British journal of cancer, 2011-02, Vol.104 (4), p.599-604 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Feb 15, 2011 ;Copyright © 2011 Cancer Research UK 2011 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2011.2 ;PMID: 21304526 ;CODEN: BJCAAI

Full text available

8
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines
Material Type:
Article
Add to My Research

A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines

Open heart, 2021-10, Vol.8 (2), p.e001725 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001725 ;PMID: 34667092

Full text available

9
Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK
Material Type:
Article
Add to My Research

Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK

British journal of cancer, 2019-07, Vol.121 (2), p.109-116 [Peer Reviewed Journal]

The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0481-y ;PMID: 31182765

Full text available

10
Association between serum resistin concentration and hypertension: A systematic review and meta-analysis
Material Type:
Article
Add to My Research

Association between serum resistin concentration and hypertension: A systematic review and meta-analysis

Oncotarget, 2017-06, Vol.8 (25), p.41529-41537

Copyright: © 2017 Zhang et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.17561 ;PMID: 28525369

Full text available

11
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis
Material Type:
Article
Add to My Research

Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

Open heart, 2020-11, Vol.7 (2), p.e001353 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2053-3624 ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2020-001353 ;PMID: 33154144

Full text available

12
Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry
Material Type:
Article
Add to My Research

Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry

Open heart, 2021-09, Vol.8 (2), p.e001721 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001721 ;PMID: 34521747

Full text available

13
Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension Patients
Material Type:
Article
Add to My Research

Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension Patients

Archivos de bronconeumología (English ed.), 2024-04, Vol.60 (4), p.253-255 [Peer Reviewed Journal]

2024 SEPAR ;ISSN: 0300-2896 ;EISSN: 1579-2129 ;DOI: 10.1016/j.arbres.2024.01.016 ;PMID: 38402048

Full text available

14
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
Material Type:
Article
Add to My Research

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

British journal of cancer, 2014-09, Vol.111 (6), p.1241-1248 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Sep 9, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.430 ;PMID: 25117820 ;CODEN: BJCAAI

Full text available

15
Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
Material Type:
Article
Add to My Research

Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension

Oncotarget, 2017-05, Vol.8 (18), p.29613-29624

Copyright: © 2017 Amirjanians et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.16769 ;PMID: 28410199

Full text available

16
Effects of renal denervation on monocrotaline induced pulmonary remodeling
Material Type:
Article
Add to My Research

Effects of renal denervation on monocrotaline induced pulmonary remodeling

Oncotarget, 2017-07, Vol.8 (29), p.46846-46855

Copyright: © 2017 Liu et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.15154 ;PMID: 28187460

Full text available

17
Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression
Material Type:
Article
Add to My Research

Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression

Oncotarget, 2016-12, Vol.7 (49), p.81241-81254

Copyright: © 2016 Franz et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.13220 ;PMID: 27835899

Full text available

18
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes
Material Type:
Article
Add to My Research

Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes

Open heart, 2023-06, Vol.10 (1), p.e002268 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002268 ;PMID: 37280015

Full text available

19
Blood pressure status, trajectories and cardiovascular disease: the CoLaus|PsyCoLaus prospective study
Material Type:
Article
Add to My Research

Blood pressure status, trajectories and cardiovascular disease: the CoLaus|PsyCoLaus prospective study

Open heart, 2024-02, Vol.11 (1), p.e002556 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002556 ;PMID: 38388190

Full text available

20
Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK
Material Type:
Article
Add to My Research

Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK

Open heart, 2021-02, Vol.8 (1), p.e001461 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2020-001461 ;PMID: 33707223

Full text available

Results 1 - 20 of 1,099  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1990  (10)
  2. 1990 To 1998  (39)
  3. 1999 To 2006  (74)
  4. 2007 To 2015  (326)
  5. After 2015  (651)
  6. More options open sub menu

Language 

  1. English  (1,016)
  2. Spanish  (95)
  3. Japanese  (59)
  4. Portuguese  (11)
  5. Norwegian  (5)
  6. More options open sub menu

Searching Remote Databases, Please Wait